Cargando…

Is the determination of C‐reactive protein really necessary in the diagnosis of Alpha‐1 antitrypsin deficiency?

Detalles Bibliográficos
Autores principales:	Hernández‐Pérez, José María, López‐Charry, Claudia Viviana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366562/ https://www.ncbi.nlm.nih.gov/pubmed/35578817 http://dx.doi.org/10.1111/crj.13494

Ejemplares similares

Is there any kind of relationship between alpha-1 antitrypsin levels and lung function parameters?
por: Hernández-Pérez, José María, et al.
Publicado: (2023)

Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency
por: María Hernández Pérez, José, et al.
Publicado: (2022)

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
por: Strassmair, Michael, et al.
Publicado: (2021)

Is CME Really Necessary?
por: Hall, G H
Publicado: (1994)

How are we in Brazil with the treatment of alpha-1 antitrypsin deficiency?
por: Castellano, Maria Vera Cruz de Oliveira, et al.
Publicado: (2022)

The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013)

Clarifying the relationship between pulmonary langerhans cell histiocytosis and Alpha 1 antitrypsin deficiency
por: McCarthy, Cormac, et al.
Publicado: (2021)

Root carving in tooth morphology – Is it really necessary?
por: Sivapathasundharam, B, et al.
Publicado: (2021)

Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection
por: Hernández Pérez, José María, et al.
Publicado: (2021)

Description of 22 new alpha-1 antitrypsin genetic variants
por: Renoux, Céline, et al.
Publicado: (2018)

Alpha 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease patients: is systematic screening necessary?
por: da Costa, Cláudia Henrique, et al.
Publicado: (2019)

Ribavirin use in pediatric patients with Crimean Congo Hemorrhagic Fever: is it really necessary?
por: Tezer, Hasan, et al.
Publicado: (2016)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Alpha(1)-antitrypsin deficiency: current perspective on research, diagnosis, and management
por: Stolk, Jan, et al.
Publicado: (2006)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Alpha-1 antitrypsin deficiency: an update on clinical aspects of diagnosis and management
por: Santos, Gabriela, et al.
Publicado: (2020)

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
por: Jardim, José R, et al.
Publicado: (2021)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Deficiency: Home Therapy
por: Annunziata, Anna, et al.
Publicado: (2021)

Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death
por: Kats-Ugurlu, Gursah, et al.
Publicado: (2010)

Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis
por: Al-Jameil, Noura, et al.
Publicado: (2017)

Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
por: Quinn, Mark, et al.
Publicado: (2020)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory
por: Luna Diaz, Landy V, et al.
Publicado: (2017)

Respuesta al artículo prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores
por: Hernández Pérez, José María, et al.
Publicado: (2019)

Detección de casos de déficit de alfa-1 antitripsina, ¿restringimos o ampliamos?
por: Hernández Pérez, José María, et al.
Publicado: (2023)

¿Puede ser la deficiencia de alfa-1 antitripsina un factor protector contra la hipertensión arterial y la cardiopatía isquémica?
por: Hernández Pérez, José María, et al.
Publicado: (2022)

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions
por: Mitchell, Ellen L., et al.
Publicado: (2017)

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.
por: Evans, H E, et al.
Publicado: (1979)

Alpha 1 Antitrypsin Deficiency in Infants with Neonatal Cholestasis
por: Monajemzadeh, Maryam, et al.
Publicado: (2013)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

The Importance of Early Identification of Alpha-1 Antitrypsin Deficiency
por: Buttar, Barjinder S, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2pdubrum1lhsakp01ftp3e8lti